The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure

NCT05989958 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
92
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hexaell Biotech Co., Ltd.